BVMD

Clinical trials for BVMD explained in plain language.

Never miss a new study

Get alerted when new BVMD trials appear

Sign up with your email to follow new studies for BVMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Gene therapy injection aims to halt rare blindness diseases

Disease control Recruiting now

This early-stage trial tests a gene therapy called OPGx-BEST1 for two rare inherited eye conditions that cause vision loss. About 10 adults with either Best vitelliform macular dystrophy or autosomal-recessive bestrophinopathy will receive a single injection under the retina in o…

Matched conditions: BVMD

Phase: PHASE1, PHASE2 • Sponsor: Opus Genetics, Inc • Aim: Disease control

Last updated May 17, 2026 12:24 UTC

BVMD

Get alerted when new BVMD trials appear

Gene therapy injection aims to halt rare blindness diseases